Logo

Twist Bioscience: Patrick Weiss, Bill Banyai

Jan 13, 2020

Twist Bioscience has promoted Patrick Weiss to chief operating officer from senior VP of R&D and general manager of data storage. It has appointed Bill Banyai as senior VP of advanced development and general manager of data storage.

Before helping to build Twist's operational infrastructure, Weiss served as President and CEO of Operon Biotechnologies. He also founded Xeragon, an RNA synthesis and bioinformatics firm acquired by Qiagen in 2002. He holds a master's degree in chemistry from the Swiss Federal Institute of Technology and is an author on several patents.

Banyai is a cofounder and director of the company and will maintain his board seat. He led the integration of Genome Compiler, which Twist acquired in 2016 and has overseen facilities expansions. Banyai previously served as VP of hardware at Complete Genomics. He holds a doctorate in optical science from the University of Arizona.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.